Borgman Anne Elizabeth
Insider CIK 1886388 · CRIS Director · STRO Chief Medical Officer · NXTC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRIS CURIS INC | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 2,340 | — | $0 | 2,340 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 18,700 | — | $0 | 18,700 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-05-01 | 2025-05-05 | 53,125 | — | $0 | 21,875 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-05-01 | 2025-05-05 | 15,938 | — | $0 | 17,812 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-05-01 | 2025-05-05 | 24,709 | $1.07 | $26.4K | 97,452 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-05-01 | 2025-05-05 | 53,125 | — | $0 | 106,223 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-05-01 | 2025-05-05 | 15,938 | — | $0 | 122,161 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 11,250 | — | $0 | 33,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-03-01 | 2025-03-04 | 4,621 | $1.59 | $7.3K | 53,098 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-03-01 | 2025-03-04 | 11,250 | — | $0 | 57,719 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-02-28 | 2025-03-04 | 37,500 | — | $0 | 75,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-02-28 | 2025-03-04 | 15,405 | $1.59 | $24.5K | 46,469 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-02-28 | 2025-03-04 | 37,500 | — | $0 | 61,874 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 18,700 | — | $0 | 18,700 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-02-29 | 2024-03-04 | 37,500 | — | $0 | 112,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-02-29 | 2024-03-04 | 37,500 | — | $0 | 37,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-02-29 | 2024-03-04 | 13,126 | $4.91 | $64.4K | 24,374 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 14,250 | — | $0 | 14,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-03-15 | 2023-03-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-03-15 | 2023-03-17 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2022-10-12 | 2022-10-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 14,250 | — | $0 | 14,250 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2021-10-01 | 2021-10-05 | 28,500 | — | $0 | 28,500 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2021-10-01 | 2021-10-05 | 10,384 | — | $0 | 10,384 | SEC↗ |